Filter
566
Text search:
World
Health
Organization,
Stop
TB
Partnership
Featured
49
162
Language
Document type
391
65
51
26
22
5
4
1
1
Countries
24
18
18
16
16
14
13
13
12
11
10
9
9
9
9
9
8
7
7
6
6
5
5
5
5
5
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
212
39
19
10
9
8
2
Toolboxes
245
31
15
14
12
12
10
7
6
6
6
6
5
5
4
3
3
3
2
2
1
1
Guidance on Implending Publi-Private Mix Approaches
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB
...
Collection of country-level good practices
Collection of country-level good practices
АДВОКАЦИЯ, КОММУНИКАЦИЯ
И СОЦИАЛЬНАЯ МОБИЛИЗАЦИЯ
В БОРЬБЕ С ТУБЕРКУЛЕЗОМ
Сборник успешного опыта проведения мероприятий
Blueprint for EECA countries, first edition
Blueprint for EECA countries, first edition
МОДЕЛЬ ПРОТИВОТУБЕРКУЛЕЗНОЙ ПОМОЩИ, ОРИЕНТИРОВАННАЯ НА НУЖДЫ ЛЮДЕЙ
Концептуальный проект модели для стран Восточной Европы и Центрально
...
Experience of national TB partnerships
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world
Technical information note. Digital Adherence Technologies (DATs) such as the smart medication container
kit can help to support people affected by TB with their treatment in a modern
and ef-fective way. These technologies are able to deliver remi
...
A Handbook for country programmes
How to make your messages on tuberculosis count
WHO/HTM/STB/2009.57
Advocacy, communication and social mobilization for TB control
Towards a world free of tuberculosis
Evidence from two pilot projects in India.
Guidelines for social mobilization
TB and poverty; TB and children; TB and women; TB, migrant
...
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
